Physician

Arthur Molina, M.D.

According to 2025 Medicare claims, Arthur Molina, M.D. (NPI: 1699718007) practices medical oncology in the Spokane-Spokane Valley, WA market, with the plurality of this provider's patient population coming from Spokane, WA. This provider's primary affiliated billing organization is CANCER CARE NORTHWEST CENTERS P S (NPI: 1922072081; TIN: 911007627) and primary practice location at 99218-1246. Molina is affiliated with the Cascadia Care Network LLC (ACO ID: A3731), PSW ACO (ACO ID: A5323), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Molina's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 258 traditional Medicare patients, billed 27,202 HCPCS/CPT codes, and received $619,334 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 416 prescription claims across 90 beneficiaries totaling $813,857 in drug costs, led by Anastrozole (Anastrozole). 2023 DME data shows 105 claims. Open Payments data shows 18 records totaling $363. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $67,542 and ending at $619,334. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $342,456 and ending at $813,857. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $2,115 to $6,124.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	259	786	$67,542
2016	231	716	$55,859
2017	268	697	$59,694
2018	277	1,726	$76,476
2019	315	1,060	$76,158
2020	160	476	$34,129
2021	346	721	$64,639
2022	367	1,086	$81,798
2023	256	495	$32,536
2024	258	27,202	$619,334

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	87	428	$342,456
2016	96	579	$892,144
2017	97	502	$646,191
2018	103	589	$1,009,779
2019	124	596	$456,514
2020	91	354	$948,248
2021	100	289	$840,274
2022	131	611	$952,880
2023	101	481	$859,906
2024	90	416	$813,857

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	129	$6,862
2022	N/R	240	$15,155
2023	N/R	105	$6,454
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	64	64	$161
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	106	235	$99
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	91	187	$13
36415	Insertion of needle into vein for collection of blood sample	148	337	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	143	323	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Anastrozole	Anastrozole	66	3,740	$993
Ondansetron Odt	Ondansetron	41	785	$672
Morphine Sulfate Er	Morphine Sulfate	21	530	$536
Letrozole	Letrozole	28	1,680	$439
Prochlorperazine Maleate	Prochlorperazine Maleate	32	391	$407

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$363	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Arthur Molina, M.D.?

Tedicare shows public-source Medicare data for Arthur Molina, M.D. (NPI 1699718007), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Arthur Molina, M.D. have ACO affiliation data?

Arthur Molina, M.D. is shown with ACO affiliation data for Cascadia Care Network LLC (MSSP, ACO ID A3731), PSW ACO (MSSP, ACO ID A5323), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Arthur Molina, M.D.?

Arthur Molina, M.D. is linked to CANCER CARE NORTHWEST CENTERS P S (billing NPI 1922072081) in the available physician profile data.

Does Arthur Molina, M.D. have Open Payments data?

Arthur Molina, M.D. has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.